Pfizer Covid jab approved for use in vulnerable primary school children
The Pfizer BioNTech coronavirus vaccine has been approved for use in vulnerable primary school children.
The Joint Committee on Vaccination and Immunisation (JCVI) updated its advice after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved the jab for five to 11-year-olds following a robust review of safety data.
In response to the Omicron variant, the committee has also advised that some older children be offered a booster dose. A low-dose version of the vaccine has been approved for those aged five to 11 who are in a clinical risk group, or who are a household contact of someone (of any age) who is immunosuppressed. They should be offered a primary course of vaccination typically two doses.
It is estimated that around 330,000 children are said to fall withi...